Skip to content
DataLookout
Menu

Tata Memorial Centre clinical trial pipeline

Get alerts when Tata Memorial Centre's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple Myeloma Interventions modified Tata Memorial CentrePhase 2 NCT07891923
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-23 NCT07891923 Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple… Phase 2 Recruiting

Active trials by phase

Phase 1/2
1
Phase 2
12
Phase 2/3
2
Phase 3
5
Not charted: 25 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 16

Get alerts when Tata Memorial Centre's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free